JPRN-UMIN000020156已完成未知
The role of glucagon secreton for glycemic control in patients with type 1 diabetes or pancreatic diabetes - Glucagon secreton in patients with type 1 diabetes or pancreatic diabetes
agasaki University Hospital0 个研究点目标入组 34 人开始时间: 2015年12月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 34
研究概览
简要总结
The levels of plasma glucagon were elevated and peaked 30 min after the mixed meal ingestion. The glucagon increments from fasting to each time point in type 1 diabetes patients were comparable to those in type 2 diabetes patients. Among the type 1 diabetes patients, the glucagon response showed no differences between the subgroups based on diabetes duration and fasting C-peptide levels.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 12years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Pregnant women Women who lactates
研究者
相似试验
已完成
不适用
Evaluation of glucagon secretion in type 2 diabetesType 2 diabetesJPRN-UMIN000033387agasaki University Hospital23
已完成
不适用
Development and Evaluation of a Glucagon Sensitivity Test in Individuals With and Without Hepatic SteatosisNon-Alcoholic Fatty Liver DiseaseGlucagon ResistanceObesityType 1 DiabetesNCT04907721University of Copenhagen65
Unknown
3 期
Glucagon Modulation of Ghrelin SecretionHealthy SubjectsObesityDiabetes Mellitus, Type 1NCT00929812Charite University, Berlin, Germany38
已完成
不适用
Alternation in glucagon secretion by dietary intake after administration of sodium glucose transporter-2 inhibitor.Type 2(non-insulin dependent) diabetes mellitusJPRN-UMIN000021977Kitasato University, School of Medicine19
Unknown
不适用
Glucagon Responses During Oral- and iv Glucose in Patients With Type 1 DiabetesHyperglucagonemiaDiabetes MellitusHyperglycemiaNCT00704795University Hospital, Gentofte, Copenhagen20